Drug diversion is a major threat in our healthcare system. This term refers to cases to in which prescription medicines are obtained or used illegally, or otherwise diverted from their intended use within patient care. The result of drug diversion can be deadly to individuals, and extremely costly to hospitals and other healthcare facilities.
Medacist Solutions Group, where I serve as Chief Technology Officer, is on the frontlines of this battle against drug diversion and has been since 1998. Medacist is the leading innovator in drug diversion analytics, and the only U.S. patent holder in this discipline. Our solutions apply artificial intelligence (AI), machine learning and data analytics to our clients’ data to pinpoint unusual patterns throughout the medication use lifecycle — from procurement to storage and management in a central pharmacy, on through doctor prescription ordering, pharmacy distribution to point of care, dispensing to doctors and nurses, and ultimately administration to the patient.